Alopecia Market Size 2022-2028- Increasing Prevalence Of Hair Loss Across The Globe Is A Key Factor Driving Market Growth

Increasing prevalence of hair loss among individuals across the globe, rising demand for efficient treatment modalities, and growing number of clinical trials are some key factors expected to drive market growth

The global alopecia market size is expected to reach USD 13.80 Billion in 2028 at a CAGR of 5.1% during the forecast period, according to the latest report by Reports and Data. Increasing prevalence of hair loss caused due to chronic diseases, rising caseload of persistent chemotherapy-induced alopecia, advancements in alopecia diagnosis and treatment, and growing number of clinical trials across the globe to develop effective treatments for alopecia are key factors expected to drive market revenue growth over the forecast period. In addition, increasing number of initiatives by government of various countries across the globe to raise awareness about the condition and to accelerate alopecia research is another key factor expected to support market revenue growth going ahead.

Alopecia is referred to as hair loss that can occur anywhere on the body. Alopecia can be divided into two main categories: scarring and non-scarring. The most common type of alopecia is androgenetic alopecia, which is a disorder that affects nearly 50% of men and 15% of women, particularly postmenopausal women. Other types of alopecia include alopecia areata, telogen effluvium, cicatricial alopecia, and traumatic alopecia, among others.

Access Free sample PDF Copy of the Report @

Alopecia is usually divided into disorders where the hair follicle is normal but there is abnormality in hair cycle and disorders where the hair follicle is damaged. Alopecia, in men and women, has been widely linked with significantly detrimental effects on body image, self-esteem, and psychological well-being. Growing prevalence of alopecia, primary and secondary, among individuals across the globe is leading to increasing demand for efficient treatment modalities that can provide satisfying and long-term results. This is further leading to development of well-designed clinical trials to evaluate safety and efficacy of newly identified molecules and compounds in treatment of alopecia and is a key factor expected to fuel revenue growth of the global market over the forecast period.

Commonly available therapeutic options for alopecia includes mesotherapy, microneedling, platelet-rich plasma, low-level laser therapy, and adipose-derived fat stem cell therapy. Increasing affordability of these therapies, growing popularity of off-label and over-the-counter medications, and rising consumption of dietary supplements to prevent and control hair loss are some other key factors expected to drive market revenue growth. However, high costs of treatments, lack of awareness among individuals in developing and underdeveloped countries, and lack of favorable reimbursement policies are some key factors that could restrain market revenue growth to a certain extent.

Some Key Highlights from the Report:

  • Alopecia areata is expected to account for largest revenue share over the forecast period, attributable to rising global incidence of alopecia areata, increasing research & development activities to understand pathophysiology of alopecia areata, development of novel treatment approaches, and growing number of clinical trials to assess efficacy and response of novel therapies and drug candidates.
  • Pharmaceuticals segment is expected to register significantly fast revenue growth rate over the forecast period, owing to rising demand for prescription drugs to treat alopecia, increasing consumption of OTC drugs and off-label oral and topical medications, and increasing affordability of these medicines.
  • Male segment is expected to account for a significantly large revenue share over the forecast period, attributed to increasing incidence of alopecia and male pattern baldness, growing consumption of alcohol and tobacco, hormonal imbalance, and rising availability of various therapies for medical management of alopecia in men.
  • Prescriptions segment is expected to register steady revenue growth rate over the forecast period, attributable to rising preference of patients to visit dermatologists and trichologists for management of alopecia, increasing disposable income, growing demand for approved medications, and availability of wide range of prescription drugs.
  • North America is expected to dominate other markets in terms of revenue share over the forecast period, attributable to increasing prevalence of hair loss among men and women, rising incidence of chemotherapy-induced alopecia among cancer patients, availability of top-of-the-line treatment and surgical modalities, and presence of key players in countries in the region.
  • Major companies profiled in the market report include Cipla Inc., Johnson and Johnson AG, Transitions Hair Pty Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Cirrus Hair Centers, Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus.

Get In detailed Research Study @

For the purpose of this report, Reports and Data has segmented the global alopecia market based on disease type, treatment, gender, distribution channel, and region:

Disease Type Outlook (Revenue, USD Billion; 2018-2028)

  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Androgenetic Alopecia
  • Others

Treatment Outlook (Revenue, USD Billion; 2018-2028)

  • Pharmaceuticals
  • Devices

Gender Outlook (Revenue, USD Billion; 2018-2028)

  • Male
  • Female

Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)

  • Prescriptions
  • Over-the-Counter

Download Summary @

Regional Outlook (Revenue, USD Billion, 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China 
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Ask for Customize Research Report @

Some points on how the report benefits stakeholders:

  • The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
  • Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
  • The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
  • The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
  • Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
  • The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.

Explore Latest Trending Research Reports By Reports and Data's

Heparin Market By Product Type (Unfractionated, Low Molecular Weight, Ultra-Low Molecular Weight), By Route of Administration (Subcutaneous, Intravenous), By Application (Coronary Artery Disease, Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region Forecast to 2028

Creatinine Test Market Size and Analysis By Test Type (Blood Test, Urine Test, and Others), By Product (Consumables, Instruments), By Application (Urinary Tract Obstruction, Renal Failure, Kidney Cancer and Glomerulonephritis, and Others), By End-Use (Hospital and Clinics, Diagnostic Centre, and Research Institutes), And By Region Forecast to 2028

Rehabilitation Robots Market Size, Share & Analysis by Type (Therapeutic, Exoskeleton, Assistive, and Others), By End Use (Hospitals, Rehabilitation Centers, Prosthetic Clinics, and Others), And By Region Forecast to 2028

Microtome Market Size, Share and Report Analysis By Product (Rotary Microtomes, Microtome Instruments, and Others), By Technology (Fully Automated Microtomes, Semi-automated Microtomes, Manual Microtomes), By Application (Disease Diagnosis, Medical Research), By End-Use (Hospital Laboratories, Clinical Laboratories, Others) and By Region, Segment Forecasts To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs

Read Latest Press Release @


Back to news